{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:13:48Z","timestamp":1789391628921,"version":"build-2803163510"},"reference-count":51,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The clinical course of patients with chronic lymphocytic leukemia (CLL) is heterogeneous. Several prognostic factors have been identified that can stratify patients into groups that differ in their relative tendency for disease progression and\/or survival. Here, we pursued a subnetwork-based analysis of gene expression profiles to discriminate between groups of patients with disparate risks for CLL progression. From an initial cohort of 130 patients, we identified 38 prognostic subnetworks that could predict the relative risk for disease progression requiring therapy from the time of sample collection, more accurately than established markers. The prognostic power of these subnetworks then was validated on 2 other cohorts of patients. We noted reduced divergence in gene expression between leukemia cells of CLL patients classified at diagnosis with aggressive versus indolent disease over time. The predictive subnetworks vary in levels of expression over time but exhibit increased similarity at later time points before therapy, suggesting that degenerate pathways apparently converge into common pathways that are associated with disease progression. As such, these results have implications for understanding cancer evolution and for the development of novel treatment strategies for patients with CLL.<\/jats:p>","DOI":"10.1182\/blood-2012-03-416461","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T20:45:23Z","timestamp":1343421923000},"page":"2639-2649","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression"],"prefix":"10.1182","volume":"120","author":[{"given":"Han-Yu","family":"Chuang","sequence":"first","affiliation":[{"name":"Bioinformatics and Systems Biology Program,"},{"name":"Department of Bioengineering,"},{"name":"Department of Medicine,"},{"name":"Moores Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rassenti","sequence":"additional","affiliation":[{"name":"Department of Medicine,"},{"name":"Moores Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Division of Biological Science, University of California, San Diego, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Licon","sequence":"additional","affiliation":[{"name":"Department of Bioengineering,"},{"name":"Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kohlmann","sequence":"additional","affiliation":[{"name":"Department of Genomics and Oncology, Roche Molecular Systems Inc, Pleasanton, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"MLL M\u00fcnchner Leuk\u00e4mielabor GmbH, M\u00fcnchen, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Division of Hematology, University La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey","family":"Ideker","sequence":"additional","affiliation":[{"name":"Bioinformatics and Systems Biology Program,"},{"name":"Department of Bioengineering,"},{"name":"Department of Medicine,"},{"name":"Moores Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Department of Medicine,"},{"name":"Moores Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2019111811304462200_B1","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111811304462200_B2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111811304462200_B3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2019111811304462200_B4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"9","key":"2019111811304462200_B5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"5439","key":"2019111811304462200_B6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"issue":"11","key":"2019111811304462200_B7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"issue":"11","key":"2019111811304462200_B8","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.","volume":"194","author":"Klein","year":"2001","journal-title":"J Exp Med"},{"issue":"19","key":"2019111811304462200_B9","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","article-title":"Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.","volume":"22","author":"Haslinger","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111811304462200_B10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3324\/haematol.11694","article-title":"Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia.","volume":"93","author":"Fernandez","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"2019111811304462200_B11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C","article-title":"CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.","volume":"91","author":"Stratowa","year":"2001","journal-title":"Int J Cancer"},{"issue":"7","key":"2019111811304462200_B12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2173","article-title":"Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?","volume":"7","author":"Sotiriou","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2019111811304462200_B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/bioinformatics\/bth469","article-title":"Outcome signature genes in breast cancer: is there a unique set?","volume":"21","author":"Ein-Dor","year":"2005","journal-title":"Bioinformatics"},{"issue":"1","key":"2019111811304462200_B14","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/gb-2003-4-1-r7","article-title":"MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data.","volume":"4","author":"Doniger","year":"2003","journal-title":"Genome Biol"},{"issue":"43","key":"2019111811304462200_B15","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"2019111811304462200_B16","doi-asserted-by":"crossref","first-page":"13544","DOI":"10.1073\/pnas.0506577102","article-title":"Discovering statistically significant pathways in expression profiling studies.","volume":"102","author":"Tian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111811304462200_B17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/bioinformatics\/btm129","article-title":"A Markov random field model for network-based analysis of genomic data.","volume":"23","author":"Wei","year":"2007","journal-title":"Bioinformatics"},{"issue":"11","key":"2019111811304462200_B18","doi-asserted-by":"crossref","first-page":"e1000217","DOI":"10.1371\/journal.pcbi.1000217","article-title":"Inferring pathway activity toward precise disease classification.","volume":"4","author":"Lee","year":"2008","journal-title":"PLoS Comput Biol"},{"issue":"7061","key":"2019111811304462200_B19","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03985","article-title":"A network-based analysis of systemic inflammation in humans.","volume":"437","author":"Calvano","year":"2005","journal-title":"Nature"},{"key":"2019111811304462200_B20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/msb4100124","article-title":"Computational analysis of the synergy among multiple interacting genes.","volume":"3","author":"Anastassiou","year":"2007","journal-title":"Mol Syst Biol"},{"key":"2019111811304462200_B21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/msb4100180","article-title":"Network-based classification of breast cancer metastasis.","volume":"3","author":"Chuang","year":"2007","journal-title":"Mol Syst Biol"},{"issue":"5","key":"2019111811304462200_B22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","article-title":"An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.","volume":"142","author":"Kohlmann","year":"2008","journal-title":"Br J Haematol"},{"issue":"15","key":"2019111811304462200_B23","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111811304462200_B24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2019111811304462200_B25","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression.","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2019111811304462200_B26","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-09-1132","article-title":"A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.","volume":"15","author":"Friedman","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7062","key":"2019111811304462200_B27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nature04209","article-title":"Towards a proteome-scale map of the human protein-protein interaction network.","volume":"437","author":"Rual","year":"2005","journal-title":"Nature"},{"issue":"6","key":"2019111811304462200_B28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2005.08.029","article-title":"A human protein-protein interaction network: a resource for annotating the proteome.","volume":"122","author":"Stelzl","year":"2005","journal-title":"Cell"},{"key":"2019111811304462200_B29","doi-asserted-by":"crossref","first-page":"D418","DOI":"10.1093\/nar\/gki051","article-title":"The Biomolecular Interaction Network Database and related tools 2005 update.","volume":"33","author":"Alfarano","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2019111811304462200_B30","doi-asserted-by":"crossref","first-page":"D428","DOI":"10.1093\/nar\/gki072","article-title":"Reactome: a knowledgebase of biological pathways.","volume":"33","author":"Joshi-Tope","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2019111811304462200_B31","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1101\/gr.1680803","article-title":"Development of human protein reference database as an initial platform for approaching systems biology in humans.","volume":"13","author":"Peri","year":"2003","journal-title":"Genome Res"},{"key":"2019111811304462200_B32","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets.","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"2019111811304462200_B33","doi-asserted-by":"crossref","first-page":"D108","DOI":"10.1093\/nar\/gkj143","article-title":"TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes.","volume":"34","author":"Matys","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2019111811304462200_B34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/nar\/29.1.242","article-title":"BIND\u2013The Biomolecular Interaction Network Database.","volume":"29","author":"Bader","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2019111811304462200_B35","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111811304462200_B36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/156652406778195008","article-title":"Molecular pathogenesis of chronic lymphocytic leukemia.","volume":"6","author":"Danilov","year":"2006","journal-title":"Curr Mol Med"},{"issue":"10","key":"2019111811304462200_B37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0145-2126(02)00035-8","article-title":"Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes","volume":"26","author":"Franks","year":"2002","journal-title":"Leukemia Res"},{"issue":"9","key":"2019111811304462200_B38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade.","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J"},{"issue":"12","key":"2019111811304462200_B39","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","article-title":"Map kinase signaling pathways and hematologic malignancies.","volume":"101","author":"Platanias","year":"2003","journal-title":"Blood"},{"issue":"44","key":"2019111811304462200_B40","doi-asserted-by":"crossref","first-page":"18956","DOI":"10.1073\/pnas.1013420107","article-title":"B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111811304462200_B41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"issue":"1-2","key":"2019111811304462200_B42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2005.09.006","article-title":"TGF-beta and cancer.","volume":"17","author":"Bierie","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2019111811304462200_B43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V89.3.941","article-title":"Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.","volume":"89","author":"Douglas","year":"1997","journal-title":"Blood"},{"issue":"3","key":"2019111811304462200_B44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1084\/jem.179.3.999","article-title":"Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.","volume":"179","author":"Lotz","year":"1994","journal-title":"J Exp Med"},{"issue":"2","key":"2019111811304462200_B45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111811304462200_B46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2174\/156800910793605794","article-title":"Wnt\/beta-catenin\/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options.","volume":"10","author":"Gandhirajan","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"issue":"7","key":"2019111811304462200_B47","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3109\/10428194.2011.654115","article-title":"p53 protein expression in chronic lymphocytic leukemia.","volume":"53","author":"Sellmann","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2019111811304462200_B48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat Genet"},{"issue":"21","key":"2019111811304462200_B49","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1182\/blood-2009-03-208256","article-title":"High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.","volume":"114","author":"Herling","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111811304462200_B50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.leu.2404017","article-title":"TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.","volume":"20","author":"Herling","year":"2006","journal-title":"Leukemia"},{"issue":"12","key":"2019111811304462200_B51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process.","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat Rev Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2639\/1358295\/zh803912002639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2639\/1358295\/zh803912002639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:39:24Z","timestamp":1574095164000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/13\/2639\/30820\/Subnetworkbased-analysis-of-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":51,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,9,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-416461","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]}}}